1. Home
  2. BBY vs NBIX Comparison

BBY vs NBIX Comparison

Compare BBY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Best Buy Co. Inc.

BBY

Best Buy Co. Inc.

N/A

Current Price

$101.23

Market Cap

18.2B

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$164.98

Market Cap

15.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBY
NBIX
Founded
1966
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2B
15.5B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
BBY
NBIX
Price
$101.23
$164.98
Analyst Decision
Hold
Strong Buy
Analyst Count
25
29
Target Price
$87.85
★ $207.50
AVG Volume (30 Days)
★ 2.8M
1.4M
Earning Date
11-24-2026
11-02-2026
Dividend Yield
★ 3.86%
N/A
EPS Growth
17.76
★ 41.95
EPS
2.79
★ 5.26
Revenue
★ $41,691,000,000.00
$161,626,000.00
Revenue This Year
$2.34
$36.46
Revenue Next Year
$1.67
$17.43
P/E Ratio
$36.33
★ $31.57
Revenue Growth
0.39
★ 977.51
52 Week Low
$55.10
$122.14
52 Week High
$101.49
$186.12

Technical Indicators

Market Signals
Indicator
BBY
NBIX
Relative Strength Index (RSI) 60.52 69.59
Support Level $59.52 $152.67
Resistance Level N/A $169.57
Average True Range (ATR) 3.54 4.61
MACD 0.27 2.82
Stochastic Oscillator 79.44 85.33

Price Performance

Historical Comparison
BBY
NBIX

About BBY Best Buy Co. Inc.

Best Buy Co Inc is a pure-play consumer electronics retailer in the USA. It has two reportable segments: Domestic and International. The Domestic and International segments have offerings in six revenue categories. Computing and Mobile Phones, Consumer Electronics, Appliances, Entertainment, Services, and Other. The company has approximately 1,068 stores throughout its Domestic and International segments. It also have vendor store-within-a-store concepts to allow closer vendor partnerships and a higher quality customer experience. The company generates majority of its revenue from the Domestic segment.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: